Latest Insider Transactions at Novo Cure LTD (NVCR)
This section provides a real-time view of insider transactions for Novo Cure LTD (NVCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NovoCure Ltd to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NovoCure Ltd's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2020
|
Asaf Danziger |
BUY
Exercise of conversion of derivative security
|
Direct |
207,910
+25.63%
|
$4,574,020
$22.0 P/Share
|
|
Dec 18
2020
|
Jeryl L Hilleman |
SELL
Open market or private sale
|
Direct |
2,500
-42.37%
|
$415,000
$166.4 P/Share
|
|
Nov 02
2020
|
Ashley Cordova Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
230
-0.87%
|
$26,910
$117.41 P/Share
|
|
Oct 29
2020
|
Pritesh Shah Chief Growth Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,468
+11.13%
|
$335,148
$11.1 P/Share
|
|
Feb 28
2020
|
Wilhelmus Cm Groenhuysen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,670
-2.39%
|
$264,240
$72.22 P/Share
|